Yesterday an earthquake shook the Kremlin when The British Sun reported that Vladimir Putin would be suffering from Parkinson's disease. Government spokesman Dmitry Peskov immediately denied: “A complete nonsense. The president is fine and in excellent health conditions ”. The Sun, according to a source who knows the [...]
read more
(by Nicola Simonetti) Some American and Australian research schools have greeted, with scientific interest, the return of the leotard as a daily garment for women and men. Although it is mainly identified as female, models are also on the market for men, who can thus take advantage of its comfort advantages. The body has a protective role [...]
read more
A world-renowned expert on brain mapping has announced the discovery of a hidden brain region in humans that may be what differentiates humans from monkeys and other animals. The discovery took place while a group of scientists was thinking about the parts of the human brain to be included in an atlas [...]
read more
(Nicola Simonetti) A hope of a solution to the tremor and other symptoms comes from Japan. is launched, with a clinical "trial". The professor. Jun Takahashi and collaborators injected, by means of a specialized device placed in the skull through a hole of 12 millimeters in diameter, in the brains of seven patients (volunteers who will be followed, step [...]
read more
The hunt by the young researchers of the Irccs Fatebenefratelli of Brescia of proteins as potential pharmacological targets to treat Alzheimer's and Parkinson's disease continues. This time it is the LRRK2 protein that is being analyzed. The study will try to understand if and how it can be associated with neuroinflammation, a characteristic present in both diseases [...]
read more
After the departure of Merck Serono, also the US pharmaceutical giant Pfizer Inc has decided to forgo investments in the research of new drugs for the treatment of degenerative diseases such as Alzheimer's and Parkinson's. The investments made were not sufficient to obtain noteworthy results against the disease. This is why the pharmaceutical company [...]
read more
It affects about 3 per thousand of the general population, and about 1% of those over the age of 65.Translated in numbers almost 300.000 individuals in Italy alone, for the most part males (1,5 times more), with age of onset between 59 and 62 years. These figures, according to scholars, are even destined to [...]
read more
The conference opens tomorrow, organized at the Gemelli Hospital in Rome in the Brasca Room, "Parkinson's disease at the Gemelli Hospital". The event aims to present the neurosurgical treatments available for the treatment of this serious and disabling neurological disease. According to national data, Parkinson's disease now affects more than [...]
read more